ArticleBMC pregnancy and childbirth2025
Maternal substance use disorder and neonatal health: epidemiologic and socioeconomic determinants in a case-control study, Shiraz, Iran.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Outcomes in offspring of interventions to treat substance use in pregnancy: protocol for an umbrella review.Systematic reviews · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeonates born to mothers with substance use disorder may require pharmacological or non-pharmacological treatments for withdrawal symptoms post-birth. This study aims to assess parents' epidemiologic and socioeconomic factors and their correlation with short neonatal outcomes, such as length of hospital stay and discharge disposition.
methodsThis case-control study was conducted in hospitals affiliated with Shiraz University of Medical Sciences. Demographic and social data of parents and neonatal outcomes, including hospital stay, Finnegan score, and discharge disposition, were extracted from hospital records. Statistical analysis was performed using SPSS, reporting means, percentages, and frequencies. Independent sample t-tests, ANOVA, and chi-square tests were used to evaluate associations between mothers' socio-demographic background and clinical status. Negative binomial regression was employed to explore risk factors for length of hospital stay.
resultsThe case group comprised 95 neonates born to mothers with substance use disorder, with 122 healthy neonates as the control group. The incidence of birth from mothers with substance use disorder was 1.4%. The mean maternal age was 32.1 ± 6.5 years. The average Finnegan score among affected neonates was 6.85 ± 1.85. Methadone was the most commonly used substance. While all control group neonates were discharged home, only 57.9% of cases were discharged home. Discharge to social services was more common among unmarried and homeless or tenant mothers. Neonates born to mothers with academic degrees had 1.54 times longer hospital stay.
conclusionThis study underscores the intricate relationship between maternal substance abuse, socioeconomic factors, and neonatal health, highlighting the necessity for targeted interventions to support mothers with substance use disorder and their infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.